Gary Middleton

Activities

  1. Academic conference
  2. A Phase II Clinical Trial with Efficacy and Toxicity Outcomes and Baseline Covariates

    Kristian Brock (Speaker), , Lucinda Billingham (Contributor), , Gary Middleton (Contributor), & Christina Yap (Contributor)

    2 Jul 2018

    Activity: Talk or presentationAcademic conference

  3. Design dilemmas in the multi-drug, genetic-marker-directed, non-comparative, multi-centre, multi-arm phase II National Lung Matrix Trial

    Lucinda Billingham (Invited speaker), , (Invited speaker), , Kristian Brock (Invited speaker), , (Invited speaker), & Gary Middleton (Invited speaker)

    26 Aug 2014

    Activity: Talk or presentationAcademic conference